1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSubstance Use Disorder Drop-In Centers (Federal Funding Source: Federal Funding) is sponsored by Pennsylvania Department of Drug and Alcohol Programs (DDAP). This grant aims to expand drop-in center services for individuals with substance use disorder (SUD) in areas of Pennsylvania experiencing high overdose deaths.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Apply for Drug and Alcohol Program Funding | Commonwealth of Pennsylvania Department of Drug and Alcohol Programs Apply for Drug and Alcohol Program Funding Grant opportunities range from funding substance use disorder (SUD) drop-in centers, harm reduction services, crisis stabilization services, pregnancy supports, loan repayment programs for the SUD workforce, to other SUD-related programs, services, and initiatives.
Competitive grant process and requirements 24-09 | Integrated Health Solutions Applications are due by Friday, January 24, 2025, at 12 pm EST. DDAP is accepting applications from primary physical health care providers, hospitals, rural health centers, or federally qualified health clinics.
These organizations should have experience and expertise in addressing SUD, and OUD, or work with community-based providers that have this experience and expertise and must have a desire to provide integrated care that addresses both behavioral health care and primary physical health needs.
\r\n This project aims to promote full integration and collaboration in clinical practice between behavioral health care and primary physical health care. This integrated care can include a specific focus on the CoCM. DDAP is accepting applications from primary physical health care providers, hospitals, rural health centers, or federally qualified health clinics.
These organizations should have experience and expertise in addressing SUD, and OUD, or work with community-based providers that have this experience and expertise and must have a desire to provide integrated care that addresses both behavioral health care and primary physical health needs.
This project aims to promote full integration and collaboration in clinical practice between behavioral health care and primary physical health care. This integrated care can include a specific focus on the CoCM. Applicants must be primary physical health care providers, hospitals, rural health centers, or federally qualified health clinics.
These organizations should have experience and expertise in addressing substance use disorder (SUD), opioid use disorder (OUD) or work with community-based providers that have this experience and expertise and must have a desire to provide integrated care that addresses both behavioral health care and primary physical health needs. \r\n This integrated care can focus on the Collaborative Care Model (CoCM).
The CoCM is an evidence-based, integrated care approach that addresses substance use conditions in primary care settings. Care is provided by a primary care team that includes a case manager, behavioral health professionals, and a consulting doctor with a specialty in addiction. \r\n Applicants can also choose another evidence-based integrated care model.
Applicants cannot be involved in a current integrated behavioral health and physical health implementation project. \r\n Single County Authorities (SCAs) are not eligible to be the primary applicant under this funding announcement but may partner with one of the physical health providers mentioned above.
\r\n Department of Drug and Alcohol Programs (DDAP)- licensed treatment providers are not eligible to be the primary applicant under this funding announcement but may partner with one of the physical health providers mentioned above Applicants must be primary physical health care providers, hospitals, rural health centers, or federally qualified health clinics.
These organizations should have experience and expertise in addressing substance use disorder (SUD), opioid use disorder (OUD) or work with community-based providers that have this experience and expertise and must have a desire to provide integrated care that addresses both behavioral health care and primary physical health needs. This integrated care can focus on the Collaborative Care Model (CoCM).
The CoCM is an evidence-based, integrated care approach that addresses substance use conditions in primary care settings. Care is provided by a primary care team that includes a case manager, behavioral health professionals, and a consulting doctor with a specialty in addiction. Applicants can also choose another evidence-based integrated care model.
Applicants cannot be involved in a current integrated behavioral health and physical health implementation project. Single County Authorities (SCAs) are not eligible to be the primary applicant under this funding announcement but may partner with one of the physical health providers mentioned above.
Department of Drug and Alcohol Programs (DDAP)- licensed treatment providers are not eligible to be the primary applicant under this funding announcement but may partner with one of the physical health providers mentioned above Applications shall be submitted via email to RA-DAGrantsMgmt@pa. gov through Friday, January 24, 2025, by 12:00 pm, EST. Applications shall be submitted via email to RA-DAGrantsMgmt@pa.
gov through Friday, January 24, 2025, by 12:00 pm, EST. Application details and requirements Questions shall be submitted via email to RA-DAGrantsMgmt@pa. gov through Friday, January 10, 2025, by 12:00 pm EST.
\r\n Questions and answers will be posted here on Friday, January 17, 2024, by 12:00 pm EST. Questions shall be submitted via email to RA-DAGrantsMgmt@pa. gov through Friday, January 10, 2025, by 12:00 pm EST.
Questions and answers will be posted here on Friday, January 17, 2024, by 12:00 pm EST. Submit applications and direct questions or feedback to: Submit applications and direct questions or feedback to: Note the specified time period for questions designated for each grant opportunity under the "Questions" heading. Note the specified time period for questions designated for each grant opportunity under the "Questions" heading.
According to the current listing, eligibility includes: Existing drop-in centers in Allegheny, Philadelphia, Bucks, Delaware, and Montgomery counties. Single County Authorities (SCAs) and DDAP-licensed treatment providers are not eligible. Confirm the full requirements in the official notice before applying.
The current listing shows up to $650,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Substance Use Disorder Drop-In Centers (Federal Funding Source: Federal Funding) is funded by Pennsylvania Department of Drug and Alcohol Programs (DDAP). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Delaware. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Commonwealth Financing Authority's statewide Local Share Account program accepts applications September 1 through November 30, 2026, funding public-interest projects from $25,000 in eligible costs up to $1,000,000 per grant request out of Pennsylvania gaming revenue. Nonprofits are not eligible applicants and must be sponsored by a county, municipality, authority, or development agency. Here is how the sponsorship structure actually works, what the three-month window is really for, and why the ownership-and-maintenance clause decides more applications than the project narrative.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read article